Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Clinical News

Glassia: Ph Ii/III start

November 4, 2016 5:35 PM UTC

Kamada will "imminently" begin a U.S. Phase II/III trial of IV Glassia as an add-on to steroid treatment in about 168 GvHD patients with lower gastrointestinal involvement. An open-label portion will ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article